Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2025-12-25 @ 12:13 AM
NCT ID:
NCT00146458
Eligibility Criteria:
Inclusion Criteria:
* Newly diagnosed cervical cancer clinical stage FIGO I -IVA
* Histologically proven cervical carcinoma (including histologic types of squamous cell carcinoma, adenocarcinoma, adenosquamous carcinoma, adenoid cystic carcinoma, lymphoepithelial-like carcinoma and malignant mixed mullerian tumor)
* Presence of at least one enlarged pelvic lymph node (\>=1.0 cm in its maximal dimension), or group of small pelvic nodes (size \<1 cm), and without suspicious para-aortic lymph node metastasis or any lesion outside the pelvis by conventional MRI or CT study
* Karnofsky performance scale \>=60
* Available for concurrent chemoradiation therapy of curative intent
Exclusion Criteria:
* Cervical tumor with histologic diagnosis of verrucous carcinoma or small cell carcinoma
* Other serious illness or medical condition which would interfere with extended field irradiation or chemotherapy
* Past or current history of malignancy, except for curatively treated non-melanoma skin cancer
* Patients not suitable to receive PET study either by technical or psychological reasons
* Patients who are judged to be noncompliant to treatment or not accessible for follow up
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
0 Years
Study:
NCT00146458
Study Brief:
Protocol Section:
NCT00146458